Abstract
The cytotoxic activity of two bioactive molecules obtained from Croton species, caracasine acid (monomer) and micansinoic acid (dimer) belonging to the group of the seco-ent-kaurenes was evaluated against the prostate cancer cell line PC3 and human dermis fibroblasts (control cells). In addition, the combination of the monomer and dimer was realized with the antitumoral drugs taxol and adriamycin. The PC3 and normal cells were growth-inhibited in a dosedependent manner after exposure to both natural products. These two seco-ent-kaurenes exhibited practically the similar cytotoxic activity against human tumor cells but not to normal cells. The monomer and the dimer in combination with adriamycin and taxol respectively showed a synergistic effect on tumor cells, resulting that the combination of adriamycin with the monomer or dimer was more effective than with the taxol. Moreover, the combination of monomer and dimers showed a strong antagonistic effect.
Keywords: Prostate cancer, Croton micans, Seco-ent-kaurene, Monomer, Dimer, Combination index, Synergism, Tumor therapy.
Letters in Drug Design & Discovery
Title:Cytotoxic Effects of the Monomer and Dimer of 3, 4-seco-ent-kaurene from Croton Micans and their Interaction with Antitumoral Drugs on Cellular Line of Human Prostate Cancer
Volume: 10 Issue: 8
Author(s): Jennire Vivas, Felipe Sojo, Katiuska Chavez, Alírica I. Suarez and Francisco Arvelo
Affiliation:
Keywords: Prostate cancer, Croton micans, Seco-ent-kaurene, Monomer, Dimer, Combination index, Synergism, Tumor therapy.
Abstract: The cytotoxic activity of two bioactive molecules obtained from Croton species, caracasine acid (monomer) and micansinoic acid (dimer) belonging to the group of the seco-ent-kaurenes was evaluated against the prostate cancer cell line PC3 and human dermis fibroblasts (control cells). In addition, the combination of the monomer and dimer was realized with the antitumoral drugs taxol and adriamycin. The PC3 and normal cells were growth-inhibited in a dosedependent manner after exposure to both natural products. These two seco-ent-kaurenes exhibited practically the similar cytotoxic activity against human tumor cells but not to normal cells. The monomer and the dimer in combination with adriamycin and taxol respectively showed a synergistic effect on tumor cells, resulting that the combination of adriamycin with the monomer or dimer was more effective than with the taxol. Moreover, the combination of monomer and dimers showed a strong antagonistic effect.
Export Options
About this article
Cite this article as:
Vivas Jennire, Sojo Felipe, Chavez Katiuska, Suarez I. Alírica and Arvelo Francisco, Cytotoxic Effects of the Monomer and Dimer of 3, 4-seco-ent-kaurene from Croton Micans and their Interaction with Antitumoral Drugs on Cellular Line of Human Prostate Cancer, Letters in Drug Design & Discovery 2013; 10 (8) . https://dx.doi.org/10.2174/15701808113109990021
DOI https://dx.doi.org/10.2174/15701808113109990021 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Activation of Sphingosine Kinase-1 in Cancer: Implications for Therapeutic Targeting
Current Molecular Pharmacology Comparison of the Inhibitory Effects of Clotrimazole and Ketoconazole against Human Carboxylesterase 2
Current Drug Metabolism SCYL1-BP1 Affects Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells via Cyclin F and RRM2
Anti-Cancer Agents in Medicinal Chemistry Review of Noscapine and its Analogues as Potential Anti-Cancer Drugs
Mini-Reviews in Organic Chemistry Histone Modifier Differentially Regulates Gene Expression and Unravels Survival Role of MicroRNA-494 in Jurkat Leukemia
MicroRNA CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment
Current Pharmaceutical Design Subject Index To Volume 6
Current Molecular Medicine Progresses in TCM Metal-Based Antitumour Agents
Anti-Cancer Agents in Medicinal Chemistry Donepezil May Reduce Insulin-Like Growth Factor-1 (IGF-1) Levels in Alzheimer’s disease
CNS & Neurological Disorders - Drug Targets Functional Peptides and Small Molecules in Medicinal Chemistry-Part I
Current Topics in Medicinal Chemistry Steroid Receptor Ligands for Breast Cancer Targeting: An Insight into Their Potential Role As Pet Imaging Agents
Current Medicinal Chemistry 1,2,3-Triazine Scaffold as a Potent Biologically Active Moiety: A Mini Review
Mini-Reviews in Medicinal Chemistry Convenient and Efficient Method for Quality Control Analysis of 18F-Fluorocholine: For a Small Scale GMP-based Radiopharmaceuticals Laboratory Set-up
Current Radiopharmaceuticals Non-Steroidal Androgen Receptor Antagonists and Prostate Cancer: A Survey on Chemical Structures Binding this Fast-Mutating Target
Current Medicinal Chemistry Beta-Adrenoreceptor Modulation of Metabolic, Endocrine and Immunologic Function During Critical Illness
Endocrine, Metabolic & Immune Disorders - Drug Targets MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells
Current Cancer Drug Targets PET Designated Flouride-18 Production and Chemistry
Current Topics in Medicinal Chemistry Proline Oxidase (POX) as A Target for Cancer Therapy
Current Drug Targets Advances and Perspectives in Cell-Specific Aptamers
Current Pharmaceutical Design The Sodium-Iodide Symporter
Current Drug Targets - Immune, Endocrine & Metabolic Disorders